Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

High dose-B-vitamin treatment of hyperhomocysteinemia in dialysis patients.

Bostom AG, Shemin D, Lapane KL, Hume AL, Yoburn D, Nadeau MR, Bendich A, Selhub J, Rosenberg IH.

Kidney Int. 1996 Jan;49(1):147-52.

2.

Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients.

Nakhoul F, Abassi Z, Plawner M, Khankin E, Ramadan R, Lanir N, Brenner B, Green J.

Isr Med Assoc J. 2004 Apr;6(4):213-7.

3.

Homocysteine-lowering vitamin B treatment decreases cardiovascular events in hemodialysis patients.

Righetti M, Serbelloni P, Milani S, Ferrario G.

Blood Purif. 2006;24(4):379-86.

PMID:
16755160
4.

Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control study.

Bostom AG, Shemin D, Lapane KL, Miller JW, Sutherland P, Nadeau M, Seyoum E, Hartman W, Prior R, Wilson PW, et al.

Atherosclerosis. 1995 Apr 7;114(1):93-103.

PMID:
7605381
5.

Hyperhomocysteinemia in hemodialysis patients: effects of 12-month supplementation with hydrosoluble vitamins.

Tremblay R, Bonnardeaux A, Geadah D, Busque L, Lebrun M, Ouimet D, Leblanc M.

Kidney Int. 2000 Aug;58(2):851-8.

6.

B vitamins and the risk of total mortality and cardiovascular disease in end-stage renal disease: results of a randomized controlled trial.

Heinz J, Kropf S, Domröse U, Westphal S, Borucki K, Luley C, Neumann KH, Dierkes J.

Circulation. 2010 Mar 30;121(12):1432-8. doi: 10.1161/CIRCULATIONAHA.109.904672.

7.

Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients.

Azadibakhsh N, Hosseini RS, Atabak S, Nateghiyan N, Golestan B, Rad AH.

Saudi J Kidney Dis Transpl. 2009 Sep;20(5):779-88.

8.

[The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].

Lovcić V, Kes P, Zeljko R, Kusec V.

Acta Med Croatica. 2006 Jun;60(3):201-8. Croatian.

PMID:
16933832
9.

Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.

Gonin JM, Nguyen H, Gonin R, Sarna A, Michels A, Masri-Imad F, Bommareddy G, Chassaing C, Wainer I, Loya A, Cary D, Barker LF, Assefi A, Greenspan R, Mahoney D, Wilcox CS.

J Nephrol. 2003 Jul-Aug;16(4):522-34.

PMID:
14696754
10.

Association of B vitamins status and homocysteine levels in elderly Taiwanese.

Chen KJ, Pan WH, Yang FL, Wei IL, Shaw NS, Lin BF.

Asia Pac J Clin Nutr. 2005;14(3):250-5.

11.

What is the meaning of homocysteine in patients on dialysis?

Silva de Almeida CC, Guerra DC, Vannucchi MT, Geleilete TJ, Vannucchi H, Chiarello PG.

J Ren Nutr. 2011 Sep;21(5):394-400. doi: 10.1053/j.jrn.2010.12.005.

PMID:
21439851
12.

Effective homocysteine-lowering vitamin B treatment in peritoneal dialysis patients.

Righetti M, Tommasi A, Lagona C, La Rosa L, Uccellini M, Sessa A.

Perit Dial Int. 2004 Jul-Aug;24(4):373-7.

13.

Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.

Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, Weger M.

Z Kardiol. 2004 Jun;93(6):439-53. Review.

PMID:
15252738
14.

Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients.

Bostom AG, Shemin D, Lapane KL, Nadeau MR, Sutherland P, Chan J, Rozen R, Yoburn D, Jacques PF, Selhub J, Rosenberg IH.

Atherosclerosis. 1996 Jun;123(1-2):193-202.

PMID:
8782850
15.

A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease.

Kang JH, Cook N, Manson J, Buring JE, Albert CM, Grodstein F.

Am J Clin Nutr. 2008 Dec;88(6):1602-10. doi: 10.3945/ajcn.2008.26404.

16.

Effect of daily vitamin B-12 and folic acid supplementation on fracture incidence in elderly individuals with an elevated plasma homocysteine concentration: B-PROOF, a randomized controlled trial.

van Wijngaarden JP, Swart KM, Enneman AW, Dhonukshe-Rutten RA, van Dijk SC, Ham AC, Brouwer-Brolsma EM, van der Zwaluw NL, Sohl E, van Meurs JB, Zillikens MC, van Schoor NM, van der Velde N, Brug J, Uitterlinden AG, Lips P, de Groot LC.

Am J Clin Nutr. 2014 Dec;100(6):1578-86. doi: 10.3945/ajcn.114.090043.

17.

Homocysteine and C-reactive protein levels in haemodialysis patients.

Koulouridis E, Tzilianos M, Katsarou A, Costimba I, Klonou E, Panagiotaki E, Georgalidis C, Krokida A, Delaportas N, Lachanas A, Karaliotas G, Kaliolia I.

Int Urol Nephrol. 2001;33(2):207-15.

PMID:
12092633
18.
19.

Effect of Vitamin B12 supplementation on serum homocysteine in patients undergoing hemodialysis: A randomized controlled trial.

Tayebi A, Biniaz V, Savari S, Ebadi A, Shermeh MS, Einollahi B, Rahimi A.

Saudi J Kidney Dis Transpl. 2016 Mar;27(2):256-62. doi: 10.4103/1319-2442.178255.

20.

Hydroxocobalamin reduces hyperhomocysteinemia in end-stage renal disease.

Elian KM, Hoffer LJ.

Metabolism. 2002 Jul;51(7):881-6.

PMID:
12077735
Items per page

Supplemental Content

Support Center